Ünlü Mehmet Taner, Aygun Nurcihan, Kostek Mehmet, Caliskan Ozan, Uludag Mehmet
Department of General Surgery, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Department of General Surgery, Ümraniye Training and Research Hospital, Istanbul, Türkiye.
Front Endocrinol (Lausanne). 2025 Jul 30;16:1629719. doi: 10.3389/fendo.2025.1629719. eCollection 2025.
In primary hyperparathyroidism(pHPT), suppression in other glands due to autonomy of pathological gland is frequently observed. In this retrospective study, we aimed to evaluate contribution of suppression of remaining parathyroid glands in pHPT in predicting surgical cure.
We retrospectively analyzed data from patients diagnosed with pHPT and operated at our institution between 2014 and 2022. Patients who demonstrated either a decrease of more than 50% in intraoperative parathormone levels or a normal parathormone (PTH) level at the 6th postoperative hour were included. Patients were categorized into two groups based on their PTH levels at the 6th postoperative hour: those with PTH suppression (PTH < 15 ng/L) and those without (PTH > 15 ng/L). We analyzed the outcomes in terms of persistent disease and biochemical markers.
Among 196 patients who met the inclusion criteria, 124 exhibited PTH suppression while 72 did not. Persistent disease was significantly more common in the non-suppressed group (19.4% . 5.65%, p<0.001). Furthermore, postoperative PTH suppression strongly correlated with surgical cure, indicated by a significant difference in the rate of normocalcemia after 6 months. Excised parathyroid tissue volumes were determined significantly lower in group 1 compared to group (0.85 ± 0.88cm32.04 ± 3.79cm3,p=0.035, respectively).There was no significant difference between two groups in terms of gender, preoperative Ca, magnesium, vitamin D and postoperative Ca levels.
Early postoperative PTH suppression is highly associated with surgical cure. The rate of pPHPT is significantly higher in non-suppressed patients. Therefore, in follow-up strategies of postoperative patients, the possibility of a remnant pathological gland should be considered especially in those without early PTH suppression.
在原发性甲状旁腺功能亢进症(pHPT)中,常可见到由于病变腺体的自主性导致其他腺体受到抑制。在这项回顾性研究中,我们旨在评估pHPT中剩余甲状旁腺腺体的抑制对预测手术治愈的作用。
我们回顾性分析了2014年至2022年期间在我院诊断为pHPT并接受手术的患者的数据。纳入术中甲状旁腺激素水平下降超过50%或术后第6小时甲状旁腺激素(PTH)水平正常的患者。根据术后第6小时的PTH水平将患者分为两组:PTH受抑制组(PTH<15 ng/L)和未受抑制组(PTH>15 ng/L)。我们从持续性疾病和生化指标方面分析了结果。
在196例符合纳入标准的患者中,124例表现出PTH受抑制,72例未受抑制。持续性疾病在未受抑制组中明显更常见(19.4%. 5.65%,p<0.001)。此外,术后PTH受抑制与手术治愈密切相关,6个月后血钙正常率存在显著差异表明了这一点。与第2组相比,第1组切除的甲状旁腺组织体积明显更低(分别为0.85±0.88cm³ 2.04±3.79cm³,p=0.035)。两组在性别、术前血钙、镁、维生素D和术后血钙水平方面无显著差异。
术后早期PTH受抑制与手术治愈高度相关。未受抑制的患者中pHPT的发生率明显更高。因此,在术后患者的随访策略中,尤其是在那些没有早期PTH受抑制的患者中,应考虑残留病变腺体的可能性。